Optain’s non-invasive clinical support tools harness the power of AI-enabled algorithms to analyse retinal images to screen for disease
Optain has raised $26.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
Optain's investors include Insight Partners, Northwell Health, UPMC, Informed Ventures, Meridian Ventures.
Optain is headquartered in New City, United States.
Optain’s non-invasive clinical support tools harness the power of AI-enabled algorithms to analyse retinal images to screen for disease
Optain is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Optain — Funding & Investors." VCBacked, September 10, 2025, https://www.vcbacked.co/company/optain. Accessed July 19, 2026.
VCBacked. (2025). Optain — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/optain
{{cite web |title=Optain — Funding & Investors |url=https://www.vcbacked.co/company/optain |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated